Hillenbrand (HI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for February 18, 2025, with proposals to elect four directors, approve executive compensation (Say on Pay), and ratify Ernst & Young LLP as auditor for FY2025.
Shareholders are encouraged to preregister for in-person attendance and can vote remotely; alternative arrangements will be announced if needed.
Proxy materials, including the 2024 Annual Report, are available online.
Voting matters and shareholder proposals
Proposals include election of four directors, advisory approval of executive compensation, and ratification of the independent auditor.
Board recommends voting FOR all proposals.
Shareholder proposals for the 2026 meeting are due by September 9, 2025, for proxy inclusion.
Board of directors and corporate governance
Board consists of 11 directors, with a majority being independent and diverse in gender and ethnicity.
Recent addition of a new independent director and creation of vice chairperson roles on key committees.
Board refreshment policy requires retirement after age 73; average director tenure is 7.9 years.
Board and committees meet regularly, with all directors attending at least 75% of meetings.
Board maintains a diversity policy and regularly updates its skills and experience matrix.
Latest events from Hillenbrand
- Revenue and earnings declined sharply due to divestiture and lower demand; merger closing expected Q1 2026.HI
Q1 20269 Feb 2026 - Q3 revenue up 10% but a $265M impairment led to a net loss and a reduced FY24 outlook.HI
Q3 20242 Feb 2026 - FY24 revenue up 13%, but FY25 guidance signals declines amid macro headwinds and focus on deleveraging.HI
Q4 202414 Jan 2026 - All proposals, including the merger, were approved by shareholders at the special meeting.HI
EGM 20268 Jan 2026 - Shareholders urged to vote on the proposed Lone Star merger, with board unanimous in support.HI
Proxy Filing29 Dec 2025 - Merger set at $32.00 per share after competitive bids, with litigation prompting added disclosures.HI
Proxy Filing23 Dec 2025 - Q1 revenue down 9%, net income at $6M, and 51% of Milacron sold for $287M to reduce debt.HI
Q1 202523 Dec 2025 - Shareholders will vote on a proposed merger with Lone Star, with board urging prompt approval.HI
Proxy Filing17 Dec 2025 - Shareholders to vote on $32/share cash merger, with board unanimous in recommending approval.HI
Proxy Filing2 Dec 2025